Sanofi-Aventis Reportedly In Talks With Nichi-Iko, Could Make Big Splash In Biosimilars

Toyama-based generics manufacturer Nichi-Iko is reported to be in collaboration talks with Sanofi-Aventis to expand both companies' generic drug business in Japan, including a joint effort to tap into Japan's potential follow-on biologics market